Maria Beatriz Llamusi is a highly accomplished scientist and entrepreneur in the biotech field. With a PhD in Biochemistry and Neuroscience from the University Miguel Hernández, she dedicated 13 years as a postdoctoral researcher at the University of Valencia, focusing on rare neuromuscular diseases. Her extensive research background has contributed significantly to understanding these conditions, positioning her as a leader in her field.

In 2019, Llamusi co-founded Arthex Biotech, a company that aims to develop innovative treatments for neuromuscular diseases. As the Chief Scientific Officer (CSO), she has played a critical role in driving the scientific vision and strategy of the company. Under her leadership, Arthex Biotech has progressed through multiple stages of development, including successful fundraising rounds such as Series B, which strengthened the company’s research and development efforts.

Llamusi’s contributions extend beyond academia and research, as her entrepreneurial spirit has been crucial to Arthex Biotech’s growth. As the CEO and Scientific Director, she bridges the gap between scientific research and industry, fostering collaborations that push the boundaries of biotechnology and therapeutic innovation. Her leadership and expertise continue to shape the future of treatments for neuromuscular diseases